Investigating how mitochondrial signaling affects cell behavior in age-related macular degeneration
Mitochondrial retrograde signaling in RPE heterogeneity
This study is looking at how certain cells in the eye change when they’re under stress, which might help us understand and find better treatments for age-related macular degeneration, a common cause of vision loss in older adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10873858 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of mitochondrial signaling in retinal pigment epithelial (RPE) cells, particularly in the context of age-related macular degeneration (AMD), which is a leading cause of blindness in older adults. The study examines how certain RPE cells adapt to stress by undergoing a process called epithelial to mesenchymal transition (EMT), which may contribute to the disease's progression. By using advanced techniques like CRISPR to manipulate specific genes, the researchers aim to uncover the mechanisms behind RPE cell behavior and their impact on AMD. The findings could lead to new insights into potential treatments for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with dry age-related macular degeneration who may benefit from new treatment options.
Not a fit: Patients with other forms of macular degeneration or those without retinal pigment epithelial cell involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel therapeutic strategies for treating age-related macular degeneration, potentially improving vision and quality of life for affected patients.
How similar studies have performed: Previous research has shown promising results in understanding mitochondrial roles in cell behavior, suggesting that this approach may yield valuable insights into AMD.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Datta, Sayantan — Emory University
- Study coordinator: Datta, Sayantan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.